Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Following a very successful start to 2022 with a high number of grants having been funded – we are in need of more staff.  As one of the larger academic CTUs in the UK – we have a need for individuals to join us in the areas of office administration, trial management, statistics and programming.  

There are many exciting opportunities to contribute to funded non-commercial clinical trials across all phases of trials and in multiple areas of medicine including surgery, rheumatology, trauma, orthopaedics and oncology.  

For further information on what vacancies we currently have please visit our vacancies page

For any informal enquiries about our posts – please email octrutrialshub@ndorms.ox.ac.uk or call 01865 223469.

Similar stories

Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient

The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.

Large UK trial shows bone healing ‘superpower’ in children

Most children with a severely broken wrist can be treated without surgery, according to a major NIHR-funded UK trial led by researchers at the University of Oxford. The findings suggest that a non-surgical, cast-first approach delivers similar long-term recovery while reducing the risks associated with surgery and costs.

Surgery unnecessary for elbow fractures in children new study finds

Researchers at NDORMS have found that surgery for a displaced medial epicondyle fracture of the elbow in children offers no clinical benefit compared to non-surgical care. The findings could have significant implications for treatment and offer huge cost savings to the NHS.